Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Tae-Wha Kim"'
Autor:
A. Ostor, Mitsumasa Kishimoto, B. Combe, X. Wang, Tae-Wha Kim, Walter P. Maksymowych, D. van der Heijde, F. Van den Bosch, Alvina D. Chu, J. Sieper, I. H. Song, Y. Sui, A. Deodhar
Publikováno v:
Annals of the Rheumatic Diseases. 80:85-86
Background:Upadacitinib (UPA) was efficacious and well tolerated vs placebo (PBO) during the first 14 weeks (wks) of the phase 2/3 SELECT-AXIS 1 study in patients (pts) with active ankylosing spondylitis (AS) who had an inadequate response to NSAIDs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89cc27e643c661b6788cfdc729d2affa
https://doi.org/10.1136/annrheumdis-2021-eular.473
https://doi.org/10.1136/annrheumdis-2021-eular.473
Publikováno v:
2019 Conference on Lasers and Electro-Optics Europe & European Quantum Electronics Conference (CLEO/Europe-EQEC).
Laser beams with Laguerre-Gaussian (LG) modes are attractive to numerous applications in a number of areas including optical trapping and manipulation, super-resolution microscopy, high-capacity optical communication, quantum information, and laser m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8476c9242e798c1fb8a00bcbad852079
https://doi.org/10.1109/cleoe-eqec.2019.8872592
https://doi.org/10.1109/cleoe-eqec.2019.8872592
Publikováno v:
Annals of the Rheumatic Diseases. 80:716.1-716
Background:CT-P13, an infliximab biosimilar, is effective for treating ankylosing spondylitis (AS) at a dose of 5 mg/kg infused once every 6–8 weeks. Evidence suggests that patients with AS may benefit from a lower dose, and individualised dose/int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc4f01d091cae5015fcb6880cb73d70a
https://doi.org/10.1136/annrheumdis-2021-eular.1055
https://doi.org/10.1136/annrheumdis-2021-eular.1055
Autor:
Tae-Ho Kim, Sang-Hee Jo, Yu Jeong Lee, Mira Kim, Eun Jeong Won, Ju-Young Kim, Pu-Reum Park, Seung-Cheol Shim, So-Hee Jin, Tae-Wha Kim
Publikováno v:
Annals of the Rheumatic Diseases. 79:1122.2-1123
Background:Ankylosing Spondylitis (AS) is a chronic inflammatory rheumatic disease, which is characterized by the enthesitis, peripheral arthritis, and chronic inflammation of the spine, leading to bony ankylosis. Signal transducer and activator of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b80c4236df64ce34ea18a6c3ace64deb
https://doi.org/10.1136/annrheumdis-2020-eular.4123
https://doi.org/10.1136/annrheumdis-2020-eular.4123
Publikováno v:
Annals of the Rheumatic Diseases. 79:1358.2-1358
Background:Irisin, exercise-mediated myokine, is one of the most recently discovered hormones. Irisin has been shown to play multifunctional roles including anti-inflammation by suppressing secretion of NF kß, TNF-α, IL-6, and other pro-inflammator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52e0b6a7dd8268a6d49436326c4651fd
https://doi.org/10.1136/annrheumdis-2020-eular.5034
https://doi.org/10.1136/annrheumdis-2020-eular.5034
Autor:
Ga Young Ahn, D. Son, Yong Joo Kim, Tae Han Lee, G. G. Song, Junsun Kim, Bon San Koo, Tae-Wha Kim, Juyeon Kang
Publikováno v:
Annals of the Rheumatic Diseases. 79:1246.1-1246
Background:With the promising efficacy and the prevalent use of anti-tumor necrosis factor-α (TNF) agents in managing AS, the risk for reactivation of latent tuberculosis infection (LTBI) still is a concern. Although guidelines include the screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b89ac6daaf46a38cd6e1e9bfbaea4042
https://doi.org/10.1136/annrheumdis-2020-eular.5959
https://doi.org/10.1136/annrheumdis-2020-eular.5959
Publikováno v:
Annals of the Rheumatic Diseases. 79:728.1-729
Background:In the treatment of ankylosing spondylitis (AS), conventional disease-modifying antirheumatic drugs (cDMARDs) are generally recommended only in patients with peripheral arthritis. However in daily clinical practice, sulfasalazine (SSZ) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78f2c953f32d1b5fda9d64b1ab433175
https://doi.org/10.1136/annrheumdis-2020-eular.3116
https://doi.org/10.1136/annrheumdis-2020-eular.3116
Publikováno v:
Saturday, 16 JUNE 2018.
Background 1 alpha 25-dihydroxyvitamin D3 (1,25D) is the active form of vitamin D3, which is responsible for osteoblast activation, subsequently bone formation. Although recent studies have shown that 1,25D stimulates RANKL expression in osteoblast d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6426082152929845ce21fd2c2dd61b51
https://doi.org/10.1136/annrheumdis-2018-eular.6055
https://doi.org/10.1136/annrheumdis-2018-eular.6055
Publikováno v:
WEDNESDAY, 13 JUNE 2018.
Background Biologic drugs targeting the inflammatory cytokines have been recommended in rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Yet, some patients require a change in treatment because an adequate response is not achieved. Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::735a16698316e02003612759b06d53b5
https://doi.org/10.1136/annrheumdis-2018-eular.2007
https://doi.org/10.1136/annrheumdis-2018-eular.2007
The aims of this study were to assess the reliability of a novel magnetic resonance imaging (MRI) scoring system for inflammatory lesions of facet joints and to clarify the clinical significance of facet joint inflammation in ankylosing spondylitis (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8633d14c5dbf27eec2b53360aec80f01
